Pink Caravan has called upon women who previously underwent mammogram screenings at clinics during their annual UAE-wide breast cancer awareness campaign in 2019, to get themselves tested again at the Pink Caravan Medical Mobile Clinic.
The UAE has authorised the emergency use of Sotrovimab, a monoclonal antibody, for the treatment of patients aged 12 years or older with mild to moderate COVID-19 disease who are at risk of progression to hospitalisation or death.
According to the results, released by the health ministry, the medicine, Sotrovimab, was given to more than 650 patients with coronavirus 46 per cent of whom are citizens and 54 per cent of whom are residents. Majority of the patients are aged 50 or above.
Incorporating genomics into the healthcare ecosystem is part of the UAE’s efforts to carry out therapeutic and preventative programmes that help reduce the prevalence of genetic disorders.
In line with the National COVID-19 Vaccination Plan, UAE’s Ministry of Health and Prevention recently approved the emergency use of Pfizer-BioNTech vaccine for the 12-15 age group, following the completion of clinical trials...
Kholoud Abdullah Al Ali, Director of the Home Care Department, said that the mobile clinics, which has three units: medical unit, physiotherapy unit and dental unit, reach the elderly, bed-ridden and the disabled at their homes.
The health ministry also reported 3,658 recoveries and 5 deaths due to COVID-19 complications. The ministry expressed its sincere condolences to the families of the deceased and prayed to Almighty Allah for the speedy recovery of the infected cases.
To provide parents, students and staff members in private schools in Dubai with an effective and convenient mechanism to address COVID-19 related queries, the Dubai Health Authority has launched a dedicated 24/7 back-to-school helpline at phone number 800588.
The launch of this service reinforces the authority’s commitment to provide effective communication channels to the community, offering timely and accurate health information.
Between June 30 and July 13, Sotrovimab was administered to 6,175 patients with COVID-19 in Abu Dhabi. About 52 per cent of the patients were aged 50 or above, and almost all recipients had multiple comorbidities including obesity, cancer, cardiovascular disease and diabetes.